A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab
Joint Authors
Reynolds, G. J.
Poushanchi, Behdod
Vallabh, Hiren
Source
Case Reports in Gastrointestinal Medicine
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-02-06
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Ipilimumab is a monoclonal antibody that works as an immunotherapeutic agent through selective targeting of T cells to strengthen the response to metastatic melanoma.
It is well known that this pharmaceutical agent can cause the adverse effect of colitis.
We report a rare presentation of ileocolitis refractory to both glucocorticosteroids and infliximab with a resultant pneumatosis and perforation requiring subtotal colectomy and end ileostomy.
American Psychological Association (APA)
Poushanchi, Behdod& Vallabh, Hiren& Reynolds, G. J.. 2018. A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab. Case Reports in Gastrointestinal Medicine،Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1143417
Modern Language Association (MLA)
Poushanchi, Behdod…[et al.]. A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab. Case Reports in Gastrointestinal Medicine No. 2018 (2018), pp.1-3.
https://search.emarefa.net/detail/BIM-1143417
American Medical Association (AMA)
Poushanchi, Behdod& Vallabh, Hiren& Reynolds, G. J.. A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab. Case Reports in Gastrointestinal Medicine. 2018. Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1143417
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1143417
